PMLiVE10h
AstraZeneca/Daiichi Sankyo’s Enhertu granted FDA approval in breast cancer
AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the US Food and Drug ...
PMLiVE10h
The silent treatment – researching gene silencing for Alzheimer’s, Parkinson’s and motor neurone disease
In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...
PMLiVE10h
BMS presents promising data for immunotherapy combination in phase 3 colorectal cancer trial
Bristol Myers Squibb (BMS) has shared promising results from a late-stage study of its dual immunotherapy combination in ...
PMLiVE10h
Roche/Sarepta announce two-year results for Duchenne muscular dystrophy gene therapy
Roche and Sarepta Therapeutics have shared positive top-line results from a late-stage study of Elevidys (delandistrogene ...
PMLiVE13h
Meet the Petauri experts at World EPA Congress
We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending ...
PMLiVE13h
What does HEOR really mean in 2025?
Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of ...